Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...

Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

The syringe option is cheaper for consumers ... The report determined that 4.9 million people whose health insurance covered Zepbound last year actually lost coverage of the drug in 2025.

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...

The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

But the LillyDirect Zepbound offer is for vials that patients inject themselves with, using an old-fashioned syringe. "It's a cultural phenomena," Ricks says of the drug. "It's used by millions of ...